A new report from the Association of the British Pharmaceutical Industry has determined that the United Kingdom leads Europe in early clinical phases but falls short when it comes to later stage studies.
Cell therapies, where cellular material is injected, grafted or implanted into a patient to treat a range of illnesses and medical conditions, are a vital and integral component of medicine today – promising treatment of tissue degenerative diseases, cancer, and autoimmune disorders. However, significant challenges currently exist to prevent its widespread adoption including problems such as safety, potency, efficacy, and costs. To overcome these challenges, the Singapore-MIT Alliance for Research and Technology (SMART), together with A*STAR Institutes and supported by…
